CAR-T CDMOs with Clean FDA Inspection History
CAR-T CDMOs manufacture engineered T-cell products, combining viral-vector transduction, T-cell activation and expansion, and rapid release testing — usually as autologous, per-patient batches on tight vein-to-vein timelines.
Choosing a CAR-T CDMO depends on autologous vs allogeneic experience, in-house vs sourced vector, closed-system processing, and chain-of-identity logistics, alongside a clean regulatory record. The rankings below score each CDMO on FDA inspections, GMP certification, clinical activity, and capacity.
FDA inspection outcomes across these CDMOs: 24 NAI (no action), 24 VAI (voluntary action), 0 OAI (official action). Leading inspection & GMP sites: United States (35), Austria (30), Denmark (23), Slovenia (13), Germany (12).
Last updated 2026-10-20. Sourced from FDA, EMA EudraGMDP, MHRA GMDP, and ClinicalTrials.gov.
Ranked by Signal Score (0–100). Fully evidenced marks a CDMO scored on all four pillars with at least one confirmed clinical program. Partly scored and profile-only CDMOs follow the scored rows. How we score
Showing all operator types.
| # | CDMO | Signal Score | Quality | FDA · GMP | Last FDA inspection | Capacity | Programs |
|---|---|---|---|---|---|---|---|
| 1 |
BMS
|
87.0 | 97.2 | 8 insp · 2 GMP | 2026-04-28 · NAI | — | 585 programs |
| 2 |
CR
Newbury Park, CA · Memphis, TN · Keele, UK · Rockville, MD
|
86.3 | 99.2 | 9 insp · 11 GMP | 2026-05-01 · NAI | Limited | — |
| 3 |
|
85.4 | 97.4 | 17 insp · 51 GMP | 2026-06-24 · NAI | — | 135 programs |
| 4 |
COH
|
84.0 | 97.3 | 3 insp · 0 GMP | 2025-08-20 · VAI | — | 213 programs |
| 5 |
MN
Philadelphia, PA · Allendale, NJ · Munich, DE · Yokohama, JP
|
83.1 | 99.2 | 3 insp · 4 GMP | 2025-11-25 · NAI | Limited | — |
| 6 |
WB2
Shanghai, CN · Wuxi, CN
|
82.7 | 99.6 | 1 insp · 4 GMP | 2026-07-03 · VAI | — | — |
| 7 |
SC
Prague, Czech Republic
|
81.6 | 100.0 | 0 insp · 5 GMP | None on file | — | — |
| 8 |
NV
Morris Plains, NJ · Stein, CH
Fully evidenced
Also makes its own products
|
81.4 | 97.4 | 2 insp · 0 GMP | 2025-07-11 · VAI | Constrained | 284 programs |
| 9 |
CF
Les Ulis, FR
|
80.3 | 100.0 | 0 insp · 4 GMP | None on file | — | — |
| 10 |
AG
Longmont, CO · Milan, IT · Copenhagen, DK · Chiba, JP
Hiring · 38 open roles
Fully evidenced
|
79.9 | 99.8 | 4 insp · 27 GMP | 2026-05-29 · NAI | Available | 2 programs |
| 11 |
RC
|
79.3 | 96.8 | 1 insp · 1 GMP | 2025-01-21 · VAI | Available | — |
| 12 |
MB
|
73.0 | 100.0 | 0 insp · 2 GMP | None on file | — | 8 programs |